BASF Corporation v Carpmaels and Ransford (A Firm)

JurisdictionEngland & Wales
JudgeMr Justice Adam Johnson
Judgment Date29 October 2021
Neutral Citation[2021] EWHC 2899 (Ch)
Docket NumberCase No: BL-2018-001464
CourtChancery Division

[2021] EWHC 2899 (Ch)

IN THE HIGH COURT OF JUSTICE

BUSINESS & PROPERTY COURTS OF ENGLAND AND WALES

BUSINESS LIST (ChD)

7 Rolls Buildings

Fetter lane, London

EC 4A 1NL

Before:

Mr Justice Adam Johnson

Case No: BL-2018-001464

Between:
(1) BASF Corporation
(2) BASF Catalysts Germany GmbH
(3) BASF Polska SP.z.o.o
(4) BASF South Africa (Pty) Ltd
Claimants
and
Carpmaels and Ransford (A Firm)
Defendant

Roger Stewart QC, Pippa Manby and Miles Copeland (instructed by Reed Smith LLP) for the Claimants

John Wardell QC, Henry Ward and Nick Zweck (instructed by Clyde & Co LLP) for the Defendant

Hearing dates: 14, 15, 16, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30 April and 10, 13, 14 May 2020

Approved Judgment (Without Confidential Annex)

I direct that pursuant to CPR PD 39A para 6.1 no official shorthand note shall be taken of this Judgment and that copies of this version as handed down may be treated as authentic.

Mr Justice Adam Johnson

CONTENTS

Paragraph

I

Introduction

1

II

The Witnesses

16

The Factual Witnesses

17

The Claimants' Factual Witnesses

17

The Defendants' Factual Witnesses

27

The Expert Witnesses

31

The Claimants' Experts

31

The Defendants' Experts

35

III

Some Preliminary Points

41

Selective Catalytic Reduction

42

The Euro 6 Legislation

44

The Catalyst Suppliers and the OEMs

45

Copper Chabazite

48

Selective Catalytic Reduction on Filter

51

IV

The 458 Patent

53

V

Chronological Background

74

The Claimants and their Relationship with Carpmaels

75

The CuCHA Patents and Daimler

80

VW/Audi a Main Target

83

Awareness of the 458 Patent

88

Use of the SCRoF Patent Estate

93

Meeting with JMI: Cross-Licensing proposal – October 2011

96

Agreement with JMI for CuCHA Licence

99

JMI Request Licence of the SCRoF Patents

103

The Opposition Division hearing in relation to the 458 Patent

105

The Breach and Its Immediate Aftermath

119

JMI's Reaction to Carpmaels' breach

129

CuCHA Licence with JMI Endorsed by the BASF IP Committee

130

The Opposition Division's Preliminary Opinion and Decision on Reinstatement

131

The JMI CuCHA Licence is Documented

135

The SCRoF market: the First RFQs

136

The Divisional Application

140

Daimler Award

142

PSA and Umicore

146

VW Award

150

BASF Patent Strategy

153

Further Negotiations with Umicore

156

Dr Howard's Advice on Res Judicata and Double-Patenting

161

Ford RFQ for Panther Phase I

165

PSA Award to Umicore

166

Mr LoCascio's Strategy Document

172

Negotiations with Umicore Conclude

175

Ford Awards

176

Progress on the Divisional

179

Other RFQs

183

US Litigation: JMI Requests a SCRoF Licence

184

Mr Kumar Engages with Audi

187

JMI Further SCRoF Licence Request

195

The Divisional Patent: JMI Again Request a Licence for SCRoF

196

The two-step licence strategy for SCRoFs

199

Negotiations with VW fail to progress: discussions open up with Umicore and JMI

210

JMI is Awarded SCRoF Business After the Grant of the Divisional Patent

213

BASF Continuing Concerns over Market Share

214

SCRoF Licence with Umicore

215

SCRoF Licence with JMI

216

BASF Continues to face challenges with its SCRoF products

218

JMI's Challenge to the Divisional Patent

219

VI

The Claimants' Case at Trial

221

VII

Patent Validity

227

VIII

BASF's Technology

248

IX

To Whom Were Duties Owed by Carpmaels?

262

The Background and the Issues

262

Improved Licence Fee

264

Lost Profits on Sales

265

Some Key Facts

277

BASF Corp

285

The Second to Fourth Claimants

294

Express or Implied Retainer

296

Duty of care

311

X

The Claimants' Case on Loss – The Legal Approach

322

XI

The Claimants' Case on Loss – the 2012–2015 period

347

Overview and General Points

347

Freedom to Operate: IP Rights and market share

358

JMI would still have bid for business in the counterfactual

379

No evidence that the existence of a patent was regarded as business critical

403

The 2012–2015 period – Lost profits on Sales

413

Daimler: March 2013 RFQ

416

VW: March 2013 RFQ

420

Ford

425

The 2012–2015 period – Lost Licence Income

428

No Sufficient proof of Loss

428

Quantum

441

XII

The post-2015 period – the Lost Appeal

451

XIII

Overall Conclusion

464

I Introduction

1

This is a professional negligence claim. The Claimants are all companies in the BASF Group. The BASF Group (where convenient I will refer to it as “ BASF”) specialises in the research, development, manufacture and supply of chemical products.

2

The Defendant, Carpmaels and Ransford (“ Carpmaels”), is a partnership and a well-known firm of patent attorneys.

3

Carpmaels were instructed to prosecute a patent. This was European patent EP 1 663 458, referred to in these proceedings as “ Patent 458” or the “ 458 Patent.” Patent 458 concerned an emissions treatment system and method for use in the automotive industry. In summary it related to the idea of combining a catalyst and filter together, by putting a coat of catalyst material onto a filter unit. This gives rise to an acronym which has achieved much prominence in these proceedings, namely “ SCRoF”, referring to “ Selective Catalytic Reduction on Filter.”

4

In July 2012, in proceedings in the European Patent Office (“ EPO”), Carpmaels negligently failed to lodge an appeal to the Technical Board of Appeal (“ TBA”) from an earlier decision of the EPO's Opposition Division (“ OD”) of March 2012, revoking Patent 458 for lack of inventive step.

5

Because liability is admitted, this case is about what losses arise as a result of Carpmaels' breach. Broadly, two questions arise. The first is, to whom did Carpmaels owe either contractual or common law duties of care? In particular, was it only to the First Claimant, or was it also the Second to Fourth Claimants? Carpmaels accept that they were retained by the First Claimant (“ BASF Corp”), but deny that they were retained by, or owed any duties to, any of the Second Claimant (“ BASF Germany”), the Third Claimant (“ BASF Polska”), or the Fourth Claimant (“ BASF South Africa”).

6

The second broad issue is about what losses in fact flow from Carpmaels' admitted breach. That involves looking at what would have happened had the appeal to the TBA been filed on time, and how that counterfactual scenario would have differed from what in fact happened. The parties are agreed that, if the appeal to the TBA had been lodged, then in law the revocation of Patent 458 would have been suspended, at least until early 2015, which the parties are agreed is when the appeal would have been heard and resolved. Suspension of revocation is an automatic effect of an appeal being lodged on time: see Article 106 of the European Patent Convention. In such cases, the relevant patent remains valid in the form in which it is granted, pending final determination of the appeal.

7

Beyond that, however, there is a substantial measure of disagreement as to what the effect would have been of Patent 458 remaining unrevoked in the counterfactual scenario during the period 2012–2015.

8

The Claimants' case, in short, is that the period between July 2012 and early 2015 was a critical time for the commercial exploitation of the technology reflected in the 458 Patent, and they say that the revocation of the Patent thus deprived them of something of real value. They say the 458 Patent had potential for huge practical application, because it covered a form of technology which motor vehicle manufacturers (referred to as “ Original Equipment Manufacturers” or “ OEMs”) needed at the time in order to comply with new diesel emissions standards.

9

Three important OEMs were Daimler, VW and Ford. What in fact happened was that the BASF Group was awarded some limited business by VW during the relevant period, but lost out on other valuable business with these and other OEMs, who instead favoured SCRoF technology from a rival company, Johnson Matthey International (“ JMI”). The Claimants say that, with the benefit of an unrevoked patent, they would have had a better chance to obtain (1) a larger share of business from the OEMs, and (2) licence income from JMI, since JMI would have needed a licence of BASF's technology in order to compete at all.

10

Carpmaels, on the other hand, say that in reality the Claimants were deprived of nothing of value, because (1) in practice in the relevant marketplace patent monopolies were rarely if ever exploited; (2) the BASF SCRoF technology was inferior in terms of performance to the corresponding JMI technology which the OEMs preferred; and (3) in any event Patent 458, which had already been the subject of an adverse decision by the OD, would have been regarded even in the counterfactual as nothing more than a “ zombie patent”, and therefore of no real value in negotiating or other terms.

11

The above points all depend on an analysis of what is likely to have happened in the counterfactual scenario (i.e. assuming no negligence by Carpmaels) in the period 2012 to early 2015. That analysis does not involve having to assess the lost chance of success on the appeal before the TBA, because it is concerned...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT